Category: Alnylam’s genetic disease drug succeeds key study

Alnylam’s genetic disease drug succeeds key study, shares soar

  1. Alnylam’s genetic disease drug succeeds key study, shares soar  WHTC
  2. Alnylam shares surge 40% on drug results that may herald a new type of medicine  MarketWatch
  3. Alnylam Shares Skyrocket on Clinical Study Results – Biotech Movers  TheStreet.com
  4. Cheer Alnylam’s Drug, Pause on Its Platform  Bloomberg
  5. UPDATED: Alnylam achieves breakthrough RNAi success as PhIII patisiran study hits all goals, shares soar  Endpoints News
  6. Full coverage

from Business – Google News http://whtc.com/news/articles/2017/sep/20/alnylams-genetic-disease-drug-meets-main-goal-in-key-study/

Advertisements